Intesa Sanpaolo Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$995K Buy
5,340
+2,176
+69% +$409K 0.2% 82
2026
Q1
$615K Buy
+3,164
New +$610K 0.15% 90

Other funds holding AZN

Intesa Sanpaolo Wealth Management's AZN Position: Q2 2026 in Review

Intesa Sanpaolo Wealth Management increased its AstraZeneca (AZN) stake by 69% in Q2 2026, buying an estimated $409K and bringing the position to 5,340 shares worth $995K. The position accounts for 0.2% of the portfolio, ranked #82.

Intesa Sanpaolo Wealth Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Intesa Sanpaolo Wealth Management held 5,340 shares of AstraZeneca worth $995K as of Q2 2026.
  • Intesa Sanpaolo Wealth Management bought 2,176 AstraZeneca shares in Q2 2026, an estimated $409K.
  • AstraZeneca made up 0.2% of Intesa Sanpaolo Wealth Management's portfolio in Q2 2026, its #82 holding.
  • Intesa Sanpaolo Wealth Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Intesa Sanpaolo Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.